Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001072613-26-000267·Korro Bio, Inc.
Schedule 13D ownership disclosure
Korro Bio Inc
Common Stock, par value $0.001 per share · CUSIP: 500946108
Event date: 2026-03-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- New Enterprise Associates 17, L.P.Reported CIK 0001768564
Shares: 1,435,487.00 · Class: 9.9%
- NEA Partners 17, L.P.Reported CIK 0001796820
Shares: 1,435,487.00 · Class: 9.9%
- NEA 17 GP, LLCReported CIK 0001796821
Shares: 1,435,487.00 · Class: 9.9%
- Forest BaskettReported CIK 0001277631
Shares: 1,435,487.00 · Class: 9.9%
- Ali BehbahaniReported CIK 0001613867
Shares: 1,456,677.00 · Class: 9.9%
- Carmen ChangReported CIK 0001746342
Shares: 1,435,487.00 · Class: 9.9%
- Anthony A. Florence, Jr.Reported CIK 0001559827
Shares: 1,435,487.00 · Class: 9.9%
- Mohamad H. MakhzoumiReported CIK 0001630226
Shares: 1,435,487.00 · Class: 9.9%
- Edward T. MathersReported CIK 0001328625
Shares: 1,435,487.00 · Class: 9.9%
- Scott D. SandellReported CIK 0001237289
Shares: 1,435,487.00 · Class: 9.9%
- Paul WalkerReported CIK 0001553150
Shares: 1,435,487.00 · Class: 9.9%
- Rick YangReported CIK 0001851328
Shares: 1,435,487.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-26-000267
- Form type
- SCHEDULE 13D/A
- Filer
- Korro Bio, Inc.
- CIK
- CIK 1703647
- Filed
- Mar 12, 2026
- Reporting period
- Mar 10, 2026
- Description
- Schedule 13D beneficial ownership